Skip to main content
. 2016 May 12;21(2):e20773. doi: 10.5812/traumamon.20773

Table 1. Patients’ Characteristics in Different Groups of Organ Failure.

Parameters Patient Group SOF vs. No Organ Failure, P Value No Organ Failure vs. MOF, P Value SOF vs. MOF, P Value
No Organ Failure, n = 47 Single Organ Failure, n = 153 Multiple Organ Failure, n = 96 P Value
Age, y 29.3 ± 13.7 33.8 ± 17.1 30.1 ± 16.1 0.11 0.29 1.00 0.25
Sex a 0.26 - - -
Male 38 (80.8) 136 (88.8) 80 (83.3) - - -
Female 9 (19.1) 17 (11.11) 16 (16.6)
Prothrombin time, sec b 15.6 ± 2.6 16.4 ± 3.8 18.6 ± 6.5 < 0.001 0.97 < 0.001 < 0.001
Activated partial Thrombin time, sec b 27.5 ± 7.3 26.5 ± 6.1 31.0 ± 13.6 < 0.001 1.00 0.11 < 0.001
Coagulopathy a < 0.001 - - -
No 45 (95.7) 142 (92.8) 74 (77.0)
Yes 2 (4.26) 1 (7.1) 22 (22.9)
Blunt injury a 42 (89.3) 139 (90.8) 90 (93.7) 0.61 - - -
Penetrating injury a 5 (10.6) 4 (9.10) 6 (6.2)
Glasgow coma scale b 11.8 ± 4.0 11.9 ± 4.3 11.10±4.9 0.37 1.00 1.00 0.52
Heart rate, /min b 90.9 ± 13.5 92.3 ± 17.2 97.9 ± 21.6 0.03 1.00 0.09 0.06
Injury a severity score 0.54 - -
< 24 143 (93.6) 143 (93.5) 89 (93.7)
> 24 16 (6.4) 10 (6.5) 6 (6.3)
Systolic BP, mmHg b 116.3 ± 12.7 120.9 ± 23.2 115.6 ± 16.7 0.09 0.50 1.00 0.13
PRBC, units b 1.08 ± 2.1 0.9 ± 1.5 1.78 ± 2.1 0.002 1.00 0.11 0.002
Pao 2 , mmHg b 251.7 ± 38.9 140.2 ± 57.4 133.2 ± 65.1 < 0.001 < 0.001 < 0.001 1.000
Pco 2 , mmHg b 34.7 ± 6.08 37.0 ± 6.3 43.8 ± 44.6 0.065 1.00 0.14 0.13
Hco3, mEq/L b 21.5 ± 4.2 22.7 ± 3.4 22.5 ± 4.8 0.20 0.23 0.56 1.000
pH b 7.3 ± 0.1 7.3 ± 0.1 7.2 ± 0.5 0.49 1.00 1.00 0.78
Sodium, meq/L b 138.6 ± 5.7 138.8 ± 5.2 138.5 ± 4.9 0.89 1.00 1.00 1.000
Potassium, meq/L b 3.8 ± 0.5 3.9 ± 0.76 4.1 ± 0. 8 0.02 0.95 0.03 0.08
SOFA score b 4.1 ± 1.2 5.5 ± 1.4 6.2 ± 1.6 < 0.001 < 0.001 < 0.001 < 0.002
Bilirubin, mg % b 0.6 ± 0.3 0.7 ± 0.4 0.9 ± 0.6 < 0.001 1.00 0.02 0.01
AST, u/L b 61.5 ± 102.8 62.4 ± 71.2 212.4 ± 237.4 < 0.001 1.00 < 0.001 < 0.001
Creatinine, meq/L b 0.6 ± 0.2 0.7 ± 0.3z 0.8 ± 0.6 0.01 0.83 0.01 0.05
Urea, meq/L b 26.4 ± 10.3 29.8 ± 14.9 37.1 ± 37.4 0.01 1.00 0.04 0.06
Hemoglobin, gms/dL b 11.9 ± 2.2 11.6 ± 2.2 10.6 ± 2.6 < 0.001 1.00 0.005 0.003
Hematocrit, % b 35.7 ± 6.2 35.0 ± 6.4 32.1 ± 7.8 < 0.001 1.00 0.01 0.004
Total leukocyte count, x/cu mm b 14376.5 ± 5865.5 14950.3 ± 6627.5 16301.0 ± 6789.7 0.1 1.00 1.00 1.00
Platelet, /cu mm b 240.4 ± 118.3 233 ± 95.5 200.6 ± 84.3 0.01 1.00 0.06 0.02
Amylase, U/L b 93 (31-309) 89 (9-645) 89.5 (30 - 1759) 0.08 1.00 0.3 0.10
Lipase U/L b 31 (17-190) 31.5 (4-350) 33.5 (9 - 526) 0.05 1.00 0.16 0.09
Length of stay, days b 5.8 ± 7.4 8.4 ± 10.0 1 0.1 ± 11.2 0.63 0.38 0.05 0.63
Infection a 0.15 - -
Yes 40 (85.11) 122 (79.7) 69 (71.8)
No 7 (14.89) 31 (20.2) 27 (28.1)
Outcome a < 0.001 - -
Dead 45 (95.74) 146 (95.4) 35 (36.4)
Alive 2 (4.26) 7 (4.5) 61 (63.5)

aValues expressed as f (%) compared between the different organ failure groups using the chi-square test.

bValues expressed as mean ± SD. compared between the different organ failure groups using analysis of variance-one way ANOVA.